Prospective randomized comparison of two defibrillation safety margins in unipolar, active pectoral defibrillator therapy

PACE - Pacing and Clinical Electrophysiology

Volumn 26, Issue 2 I, 2003, Pages 613-618

  Carlsson, Joerg ^a,b   Schulte, Britta ^a   Erdogan, Ali ^a   Sperzel, Johannes ^a   Güttler, Norbert ^a   Schwarz, Torsten ^a   Pitschner, Heinz F ^a   Neuzner, Joerg ^a  

^a KERCKHOFF HEART CENTER   (Germany)

^b KLINIKUM LIPPE DETMOLD   (Germany)

Author keywords

Defibrillation; Implantable cardioverter defibrillator; Safety margin

Indexed keywords

ARTICLE; AVOIDANCE BEHAVIOR; BIOTECHNOLOGY; CARDIOMYOPATHY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DEFIBRILLATION; DEFIBRILLATOR; FEMALE; HEART DILATATION; HUMAN; IMPLANTATION; MAJOR CLINICAL STUDY; MALE; PROBABILITY; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; SYNCOPE;

EID: 0037305218     PISSN: 01478389     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1460-9592.2003.00102.x     Document Type: Article

References (19)

1. Moss AJ, Hall WJ, Cannom DS, et al., for the Multicenter Automatic Defibrillator Implantation Trial Investigators. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med 1996; 335:1933-1940.
2. The Antiazrhythmics Versus Implantable Defibrillators (AVID) Investigators. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 1997; 337:1576-1583.
3. Gregoratos G, Cheitlin MD, Conill A, et al. ACC/AHA guidelines for implantation of cardiac pacemakers and antiarrhythmic devices: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Pacemaker Implantation). J Am Coll Cardiol 1998; 31:1175-1209.
4. Strickberger SA, Daoud EG, Davidson T, et al. Probability of successful defibrillation at multiples of the defibrillation energy requirement in patients with an implantable defibrillator. Circulation 1997; 96:1217-1223.
5. Strickberger SA, Man KC, Souza J, et al. A prospective evaluation of two defibrillation safety margin techniques in patients with low defibrillation energy requirements. J Cardiovasc Electrophysiol 1998; 9:41-46.
6. Neuzner J, Liebrich A, Jung J, et al. Safety and efficacy of implantable defibrillator therapy with programmed shock energy at twice the augmented step-down defibrillation threshold: Results of the prospective, randomized, multicenter Low Energy Endotak Trial. Am J Cardiol 1999; 83:34D-39D.
7. Winter J, Heil JE, Schumann C, et al. Effect of implantable cardioverter/defibrillator lead placement in the right ventricle on defibrillation energy requirements. A combined experimental and clinical study. Eur J Cardiothorac Surg 1998; 14:419-425.
8. Singer I, Lang D. Defibrillation threshold: Clinical utility and therapeutic implications. PACE 1992; 15:932-949.
9. Marchlinski FE, Flores B, Miller JM, et al. Relation of the intraoperative defibrillation threshold to successful postoperative defibrillation with an automatic implantable defibrillator. Am J Cardiol 1988; 62:393-398.
10. Mirowski M, Reid P, Winkle R, et al. Mortality in patients with implanted automatic defibrillators. Ann Intern Med 1983; 98:585-588.
11. Winkle RA, Mead RH, Ruder MA, et al. Long-term outcome with the automatic implantable cardioverter defibrillator. J Am Coll Cardiol 1989; 13:1353-1361.
12. Nisam S, Mower M, Thomas A, et al. Patient survival comparison in three generations of automatic implantable cardioverter defibrillators: Review of 12 years, 25,000 patients. PACE 1993; 16:1353-1361.
13. Weiss R, Ostrow E, Malkin R, et al. Low defibrillation energy dose (LoDED) trial: Is a five-joule safety margin enough? Circulation 1999; 100(Suppl. I):I-786.
14. Gold MR, Foster AH, Shorofsky SR. Effects of an active pectoral-pulse generator on defibrillation efficacy with a transvenous lead system. Am J Cardiol 1996; 78:540-543.
15. Windecker S, Idecker RE, Plumb VJ, et al. The influence of ventricular fibrillation duration on defibrillation efficacy using biphasic waveforms in humans. J Am Coll Cardiol 1999; 33:33-38.
16. Page RL. Effects of antiarrhythmic medication on implantable cardioverter-defibrillator function. Am J Cardiol 2000; 85:1481-1485.
17. Kühlkamp V, Mewis C, Suchalla R, et al. Effect of amiodarone and sotalol on the defibrillation threshold in comparison to patients without antiarrhythmic drug treatment. Int J Cardiol 1999; 69:271-279.
18. Bardy GH, Dolack GL, Kudenchuk PJ, et al. Prospective, randomized comparison in humans of a unipolar defibrillation system with that using an additional superior vena cava electrode. Circulation 1994; 89:1090-1093.
19. Olsovsky MR, Pelini MA, Shorofsky AH, et al. Temporal stability of defibrillation thresholds with an active pectoral lead system. J Cardiovasc Electrophyslol 1998; 9:240-244.